ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,440, issued on Jan. 27, was assigned to Kansas State University Research Foundation (Manhattan, Kan.) and The UAB Research Foundation (Birmingham, Ala.).
"Compounds with copper- or zinc-activated toxicity against microbial infection" was invented by Stefan H. Bossmann (Manhattan, Kan.), Madumali Kalubowilage (Manhattan, Kan.), Man Zhang (Cohoes, N.Y.), Anjana Delpe-Acharige (Manhattan, Kan.), Kayla Eschliman (Manhattan, Kan.), Frank Wolschendorf (Birmingham, Ala.), Olaf Kutsch (Birmingham, Ala.), Alex Dalecki (Birmingham, Ala.) and Whitney Narmore (Birmingham, Ala.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Heterocyclic compounds with a novel py...